News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Elvina Almuradova: A new era in organ preservation
Elvina Almuradova/LinkedIn
Apr 29, 2025, 18:10

Elvina Almuradova: A new era in organ preservation

Elvina Almuradova, Ambassador at European School of Oncology, shared on X about recent paper by Andrea Cercek et al. published in New England Journal of Medicine:

“In early-stage dMMR cancers, neoadjuvant PD-1 blockade achieved 92% 2-year recurrence-free survival – many patients avoided surgery. A new era in organ preservation!”

Nonoperative Management of Mismatch Repair–Deficient Tumors

Authors: Andrea Cercek et al.

Elvina Almuradova

Read insight on OncoDaily to explore more about dMMR:

“Organ Preservation in dMMR Tumors: Results from Neoadjuvant Phase II Study with Dostarlimab”

Elvina Almuradova

 

Andrea Cercek cancer dMMR Elvina Almuradova OncoDaily Oncology
Special Coverage
Blog
May 16, 2025, 13:31
Anju Aledia: Exploring Science up Close with a Magnifying Glass
Blog
May 16, 2025, 13:24
Amil Družić: The European School of Oncology's Improving Cancer Outcomes and Leadership Course in Zagreb
Oncolibrary
May 16, 2025, 13:21
FDA Approves Retifanlimab-dlwr with Chemotherapy and as Monotherapy for Advanced Squamous Cell Carcinoma of the Anal Canal
Blog
May 16, 2025, 13:01
How Countries are Engaging Stakeholders in the Development and Implementation of NCCPs - Union for International Cancer Control
Oncolibrary
May 16, 2025, 12:59
Eating Well with Mesothelioma: What You Need to Know
Blog
May 16, 2025, 12:54
Douglas Flora: Fantastic day Connecting with the Incredible Leaders at St. Elizabeth Healthcare
Blog
May 16, 2025, 12:37
Impact of Research Through Maggie’s Lung Cancer Journey - LUNGevity Foundation
Blog
May 16, 2025, 12:28
Giulio Draetta: A $150 million Gift from Kinder Foundation
Blog
May 16, 2025, 12:19
Environmental Risk Factors of Wilms Tumour - Childhood Cancer and Leukemia International Consortium
Science
May 16, 2025, 12:17
ROSALINE Trial Reports 49% Response in Lobular Breast Cancer at ESMO 2025
Oncolibrary
May 16, 2025, 11:45
DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow Metastatic Breast Cancer
Blog
May 16, 2025, 11:26
Antonio Giordano: Important question - which 1L CDK4/6i to preserve efficacy of re-cycling cell cycle in 2L?